ISSN: 2630-5720 | E-ISSN: 2687-346X
[Haydarpasa Numune Med J]
Haydarpasa Numune Med J. 2022; 62(2): 232-234 | DOI: 10.14744/hnhj.2020.13285

Hyperlactatemia Due to Linezolid Use: A Case Report

Merve Keleş Doğan, Şeyma Betül Yığcı, Duygu Yeşilyurt, Kadir Kayataş
Department of Internal Medicine, Health Sciences University, Hamidiye Faculty of Medicine, Haydarpasa Numune Health Application and Research Center, Istanbul, Turkey

Lactate is a by-product of anaerobic respiration, and is cleared from blood by the liver and kidneys. Lactate levels greater than 2 mmol/L is defined as hyperlactatemia, and higher than 4 mmol/l with acidosis is defined as lactic acidosis. It is the most common cause of metabolic acidosis in hospitalized patients. Linezolid is an antibiotic in the oxazolidinone class that directly inhibits protein synthesis in the mitochondria of bacteria and may cause lactic acidosis, which may have a high mortality. In our article, we aimed to present a case who used linezolid for pneumonia and developed hyperlactatemia on the 12th day of treatment.

Keywords: Hyperlactatemia, lactic acidosis, linezolid

Merve Keleş Doğan, Şeyma Betül Yığcı, Duygu Yeşilyurt, Kadir Kayataş. Hyperlactatemia Due to Linezolid Use: A Case Report. Haydarpasa Numune Med J. 2022; 62(2): 232-234

Sorumlu Yazar: Merve Keleş Doğan, Türkiye
Makale Dili: İngilizce
LookUs & Online Makale